1. Home
  2. EFC vs OGN Comparison

EFC vs OGN Comparison

Compare EFC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$12.70

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$8.71

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
OGN
Founded
2007
1923
Country
United States
United States
Employees
500
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EFC
OGN
Price
$12.70
$8.71
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$14.55
$11.75
AVG Volume (30 Days)
1.5M
5.6M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
12.32%
0.94%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
$43.05
$1.67
P/E Ratio
$9.50
$11.83
Revenue Growth
N/A
N/A
52 Week Low
$11.28
$5.69
52 Week High
$14.12
$13.25

Technical Indicators

Market Signals
Indicator
EFC
OGN
Relative Strength Index (RSI) 65.44 70.76
Support Level $12.37 $8.32
Resistance Level $14.00 $9.79
Average True Range (ATR) 0.22 0.48
MACD 0.14 0.37
Stochastic Oscillator 94.72 91.56

Price Performance

Historical Comparison
EFC
OGN

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. It acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: